{
  "denotations": [
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 35,
        "end": 39
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 95,
        "end": 105
      }
    },
    {
      "id": "T4",
      "obj": "Disease",
      "span": {
        "begin": 169,
        "end": 197
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 80,
        "end": 89
      }
    },
    {
      "id": "T6",
      "obj": "Chemical",
      "span": {
        "begin": 80,
        "end": 105
      }
    },
    {
      "id": "T8",
      "obj": "Chemical",
      "span": {
        "begin": 122,
        "end": 134
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "21829065_1",
  "text": "[ Analysis of the correlation with KRAS gene mutation status and the benefit of cetuximab plus irinotecan as third - line chemotherapy for the Treatment of unresectable metastatic colorectal cancer ] ."
}
